Complications after photodynamic therapy

Archives of Ophthalmology

Volumn 123, Issue 10, 2005, Pages 1347-1350

  Schnurrbusch, Ute E K ^a   Jochmann, Claudia ^b   Einbock, Wilma ^b   Wolf, Sebastian ^a  

^a University Eye Clinic Bern   (Switzerland)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; BENZOPORPHYRIN DERIVATIVE; CORTICOSTEROID;

ADULT; AGED; ARTICLE; BACKACHE; CONFIDENCE INTERVAL; DIZZINESS; DRUG EXTRAVASATION; DYSPNEA; FEMALE; FLUSHING; HEADACHE; HUMAN; HYPERTENSION; HYPESTHESIA; INJECTION SITE REACTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MYOPIA; NAUSEA; PAIN; PARESTHESIA; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY DISORDER; PRIORITY JOURNAL; PRURITUS; RASH; RETINA HEMORRHAGE; RETINA MACULA AGE RELATED DEGENERATION; SIDE EFFECT; SUBRETINAL NEOVASCULARIZATION; SYNCOPE; SYSTEMIC DISEASE; THORAX PAIN; VISUAL ACUITY; VISUAL DISORDER;

ADULT; AGED; AGED, 80 AND OVER; CHOROIDAL NEOVASCULARIZATION; EYE DISEASES; FEMALE; HUMANS; INJECTIONS; MACULAR DEGENERATION; MALE; MIDDLE AGED; MYOPIA, DEGENERATIVE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RETROSPECTIVE STUDIES; RISK FACTORS; VITREOUS BODY;

EID: 26444545048     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.123.10.1347     Document Type: Article

References (13)

1. VIP Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin: 1-year results of a randomized clinical trial: VIP report No. 1. Ophthalmology. 2001;108:841-852.
2. Bressler NM; Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials: TAP report 2. Arch Ophthalmol. 2001;119:198-207.
3. Cohen SY, Laroche A, Leguen Y, Soubrane G, Coscas GJ. Etiology of choroidal neovascularization in young patients. Ophthalmology. 1996;103:1241-1244.
4. Barbazetto I, Burdan A, Bressler NM, et al; Verteporfin in Photodynamic Therapy Study Group. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment: TAP and VIP report No. 2. Arch Ophthalmol. 2003;121:1253-1268.
5. Blinder KJ, Blumenkranz MS, Bressler NM, et al. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial: VIP report No. 3. Ophthalmology. 2003;110:667-673.
6. Verteporfin in Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularziation: verteporfin in photodynamic therapy report 2. Am J Ophthalmol. 2001;131:541-560.
7. Hesse L, Kroll P. Pneumatic displacement of submacular hemorrhage. Ophthalmology. 2000;107:2119-2120.
8. Chen SN, Ho CL, Kuo YH, Ho JD. Intravitreous tissue plasminogen activator injection and pneumatic displacement in the management of submacular hemorrhage complicating scierai buckling procedures. Retina. 2001;21:460-463.
9. Azab M, Benchaboune M, Blinder KJ, et al; Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group; Verteporfin in Photodynamic Therapy (VIP) Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin in Photodynamic Therapy Study Report No. 4. Retina. 2004;24:1-12.
10. Spaide RF, Maranan L. Neutrophil margination as a possible mechanism for verteporfin infusion-associated pain. Am J Ophthalmol. 2003;135:549-550.
11. Devine DV, Wong K, Serrano K, Chonn A, Cullis PR. Liposome-complement interactions in rat serum: implications for liposome survival studies. Biochim Biophys Acta. 1994;1191:43-51.
12. Szebeni J, Wassef NM, Rudolph AS, Alving CR. Complement activation by liposome-encapsulated hemoglobin in vitro: the role of endotoxin contamination. Artif Cells Blood Substit Immobil Biotechnol. 1995;23:355-363.
13. Schnurrbusch UE, Welt K, Horn LC, Wiedemann P, Wolf S. Histological findings of surgically excised choroidal neovascular membranes after photodynamic therapy. Br J Ophthalmol. 2001;85:1086-1091.